Scibase AB (ST:SCIB) — Market Cap & Net Worth
Market Cap & Net Worth: Scibase AB (SCIB)
Scibase AB (ST:SCIB) has a market capitalization of $463.21 Million (Skr4.30 Billion) as of June 19, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #12819 globally and #199 in its home market, demonstrating a -28.40% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Scibase AB's stock price Skr35.80 by its total outstanding shares 1022530000 (1.02 Billion). Review Scibase AB debt and liabilities to assess the company's total debt and financial obligations.
Scibase AB Market Cap History: 2015 to 2026
Scibase AB's market capitalization history from 2015 to 2026. Data shows growth from $3.37 Billion to $3.94 Billion (1.11% CAGR).
Index Memberships
Scibase AB is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
First North Sweden PI
FNSESEKPI
|
$15.84 Billion | 2.92% | #6 of 281 |
Weight: Scibase AB's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Scibase AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Scibase AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.94x
Scibase AB's market cap is 0.94 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $2.07 Billion | $6.44 Million | -$53.09 Million | 321.09x | N/A |
| 2017 | $858.32 Million | $6.86 Million | -$42.46 Million | 125.14x | N/A |
| 2018 | $341.13 Million | $6.90 Million | -$44.22 Million | 49.45x | N/A |
| 2019 | $479.78 Million | $9.28 Million | -$39.54 Million | 51.72x | N/A |
| 2020 | $508.39 Million | $9.52 Million | -$34.99 Million | 53.40x | N/A |
| 2021 | $607.42 Million | $11.73 Million | -$41.69 Million | 51.80x | N/A |
| 2022 | $420.35 Million | $17.89 Million | -$39.90 Million | 23.50x | N/A |
| 2023 | $91.77 Million | $23.25 Million | -$55.59 Million | 3.95x | N/A |
| 2024 | $45.12 Million | $29.70 Million | -$61.12 Million | 1.52x | N/A |
| 2025 | $37.96 Million | $40.46 Million | -$87.06 Million | 0.94x | N/A |
Competitor Companies of SCIB by Market Capitalization
Companies near Scibase AB in the global market cap rankings as of June 19, 2026.
Key companies related to Scibase AB by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #147 globally with a market cap of $153.73 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #207 globally with a market cap of $117.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #234 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #247 globally with a market cap of $101.86 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #147 | Abbott Laboratories | NYSE:ABT | $153.73 Billion | $88.41 |
| #207 | Stryker Corporation | NYSE:SYK | $117.79 Billion | $307.80 |
| #234 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #247 | Medtronic PLC | NYSE:MDT | $101.86 Billion | $79.34 |
Scibase AB Historical Marketcap From 2015 to 2026
Between 2015 and today, Scibase AB's market cap moved from $3.37 Billion to $ 3.94 Billion, with a yearly change of 1.11%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr3.94 Billion | +10276.81% |
| 2025 | Skr37.96 Million | -15.85% |
| 2024 | Skr45.12 Million | -50.84% |
| 2023 | Skr91.77 Million | -78.17% |
| 2022 | Skr420.35 Million | -30.80% |
| 2021 | Skr607.42 Million | +19.48% |
| 2020 | Skr508.39 Million | +5.96% |
| 2019 | Skr479.78 Million | +40.65% |
| 2018 | Skr341.13 Million | -60.26% |
| 2017 | Skr858.32 Million | -58.47% |
| 2016 | Skr2.07 Billion | -38.71% |
| 2015 | Skr3.37 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of Scibase AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $463.21 Million USD |
| MoneyControl | $463.21 Million USD |
| MarketWatch | $463.21 Million USD |
| marketcap.company | $463.21 Million USD |
| Reuters | $463.21 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Scibase AB
SciBase Holding AB (publ), a medical technology company, develops and commercializes point-of-care platforms for skin health management in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin c… Read more